Inozyme: Several Catalysts To Move Rare Disease Pipeline Programs Forward (INZY)

News Room

Inozyme Pharma (NASDAQ:INZY) is a biotech to watch because it is making traction on advancing its drug INZ-701 for the treatment of patients with rare diseases. Two programs, where progress has been made, would be the use of this drug to

Read the full article here

Share this Article
Leave a comment